Does IVF Increase Cancer Risk? What the Evidence Shows

Does IVF increase cancer risk?

Why this question is hard to answer well

This is a question patients are genuinely frightened by, and it deserves a careful answer rather than a reassuring one.

The core difficulty is confounding. Women who undergo IVF differ from women who do not in ways that independently affect cancer risk — most importantly, infertility itself, nulliparity, and the underlying conditions that caused the infertility. PCOS, for instance, carries an independent raised risk of endometrial cancer through unopposed oestrogen exposure, entirely separate from any treatment.

So a study finding higher cancer rates among women who have had IVF may be detecting the effect of infertility rather than the effect of treatment. Disentangling the two is genuinely difficult, and this is why the literature is not straightforward.

What can be said

Large studies and reviews have looked at breast, ovarian and endometrial cancer following fertility treatment. The overall picture from this body of work has been broadly reassuring, but individual studies vary and the confounding above limits how firmly conclusions can be drawn.

This page deliberately quotes no risk figures. No source available to this audit provides estimates I can verify, and quoting an unverified number on a cancer question would be worse than saying so.

What is worth knowing regardless

PCOS — now renamed polyendocrine metabolic ovarian syndrome — carries an independent raised risk of endometrial cancer where periods are absent for prolonged periods, because the lining builds under oestrogen without shedding. Ensuring the lining sheds periodically is protective, and this applies whether or not you have fertility treatment.

Ovarian hyperstimulation syndrome is a short-term risk of treatment and is well characterised. It is preventable and is discussed separately.

Existing cancer — if you have or have had cancer, fertility preservation before gonadotoxic treatment is a separate and important discussion. AUA/ASRM recommends discussing the effects of gonadotoxic therapy before treatment begins, and this is frequently done inadequately.

What to do with this question

If you have a personal or family history of breast, ovarian or endometrial cancer, or a known BRCA or Lynch syndrome variant, raise it specifically before treatment. That is a conversation with a specialist who can assess your individual risk — not something a general article can answer.

For everyone else, the honest position is that this has been studied extensively, the findings have been broadly reassuring, and the confounding makes certainty difficult.

Reviewer note

This page needs a source with current risk estimates. It deliberately contains no figures pending that.